Clinical trial
TEDDY: Spores of Bacillus Clausii in Acute Diarrhoea in Children
NCT00265369 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00265369 |
|---|---|
| Title | TEDDY: Spores of Bacillus Clausii in Acute Diarrhoea in Children |
| Official title | Comparative Efficacy and Safety of a Bacillus Clausii Probiotic Strain Versus Placebo in the Treatment of Acute Diarrhoea in Children |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diarrhea |
| Intervention type | Drug |
| Interventions | Spores of Bacillus Clausii Probiotic Strain |
| Enrollment | 420 |
| Start date | May 1, 2004 |
| First posted | Dec 14, 2005 |
| Last update posted | Jan 11, 2011 |
| Countries | Belgium, France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: